In humans, NE deficiency is a rare genetic disorder and so we took an alternative approach in testing the NE/AAT/CBG axis, utilising the relatively common paradigm of AAT deficiency. Here, SERPINA1 is linked to alpha 1-antitrypsin deficiency.